DAX24.284 +0,6%Est505.759 +0,9%MSCI World4.343 -0,1%Top 10 Crypto12,00 -4,2%Nas23.366 -1,2%Bitcoin76.963 -2,1%Euro1,1743 +0,4%Öl61,04 -2,4%Gold4.235 +0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Bayer BAY001 Siemens Energy ENER6Y DroneShield A2DMAA Oracle 871460 RENK RENK73 Deutsche Telekom 555750 TUI TUAG50 Volkswagen (VW) vz. 766403 Novo Nordisk A3EU6F Allianz 840400 Lufthansa 823212 SAP 716460 Mercedes-Benz Group (ex Daimler) 710000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Fed senkt Leitzins: DAX fester -- US-Börsen uneins -- Oracle enttäuscht beim Umsatz -- Nextdoor, Novo Nordisk, Allianz, Telekom, TUI, Rheinmetall, EOS, SAP, NVIDIA, Softbank im Fokus
Top News
Angebot wächst weiter: 59 Kryptowährungen bei finanzen.net zero verfügbar Angebot wächst weiter: 59 Kryptowährungen bei finanzen.net zero verfügbar
Aktien von Netflix, Warner Bros. & Paramount im Fokus: Trump fordert Verkauf von CNN inmitten des Übernahmekampfes Aktien von Netflix, Warner Bros. & Paramount im Fokus: Trump fordert Verkauf von CNN inmitten des Übernahmekampfes
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Schlägt dein Herz schon für ETFs? Investier bei der Commerzbank zu Top-Konditionen in Vanguard-ETFs

Semler Scientific Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
17,30 EUR +0,30 EUR +1,76 %
STU
19,11 USD -1,26 USD -6,19 %
BTT
Semler Scientific jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.264,03 Mio. EUR

KGV10,54Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1XEZJ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS81684M1045

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolSMLR

Semler Scientific Aktien News

DatumMeistgelesen
PR NewswireSemler Scientific® Announces Updated BTC Activity; Monetizes Minority Investment to Purchase BTC; Purchased Additional 871 BTC; Now Holds 3,192 BTC; YTD BTC Yield of 152.2% Since July 1, 2024
PR NewswireSemler Scientific® Announces Select Preliminary Unaudited Fourth Quarter 2024 Financial Results and Significant Unrealized Gain from Change in Fair Value of Bitcoin Holdings
PR NewswireSemler Scientific® Announces Updated BTC and ATM Activity; Purchased Additional 237 BTC; Now Holds 2,321 BTC; BTC Yield of 99.3%
PR NewswireSemler Scientific® Announces Updated BTC and ATM Activity; Purchased Additional 211 BTC; Now Holds 2,084 BTC; BTC Yield of 92.8%
PR NewswireSemler Scientific® Announces Updated BTC and ATM Activity; Purchased Additional 303 BTC; Now Holds 1,873 BTC; BTC Yield of 78.7%
PR NewswireSemler Scientific® Announces Updated BTC and ATM Activity
PR NewswireSemler Scientific® Announces BTC and ATM Activity Raised $21.5 million; Purchased Additional 215 BTC; Now Holds 1,273 BTC with BTC Yield of 37.3%
PR NewswireSemler Scientific® Reports Third Quarter 2024 Financial Results and Additional Bitcoin Purchases
PR NewswireSemler Scientific to Report Third Quarter and First Nine Months of 2024 Financial Results, Provide an Update on Bitcoin Holdings and Host Conference Call on November 4, 2024
PR NewswireSemler Scientific Announces Additional Bitcoin Purchases
PR NewswireSemler Scientific® Reports Second Quarter 2024 Financial Results and Additional Bitcoin Purchases
PR NewswireSemler Scientific to Report Second Quarter and First Half of 2024 Financial Results and Host Conference Call on August 5, 2024
PR NewswireSemler Scientific® Announces Additional Bitcoin Purchases
PR NewswireSemler Scientific® Announces Bitcoin Treasury Strategy
PR NewswireSemler Scientific® Reports First Quarter 2024 Financial Results
PR NewswireSemler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
PR NewswireSemler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
PR NewswireSemler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024
PR NewswireSemler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results
PR NewswireSemler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023
PR NewswireSemler Scientific to Present at Upcoming Investor Conference
PR NewswireSemler Scientific Reports Second Quarter and First Half of 2023 Financial Results
PR NewswireSemler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023
PR NewswireSemler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining
PR NewswireSemler Scientific to Join the Russell 2000® and 3000® Indexes
PR NewswireSemler Scientific Reports First Quarter 2023 Financial Results
PR NewswireSemler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023
PR NewswireSemler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO
PR NewswireSemler Scientific Announces Appointment of Eric Semler and William Chang as Directors
PR NewswireSemler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare Conference
PR NewswireSemler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement
PR NewswireSemler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results
PR NewswireSemler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023
PR NewswireSemler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care Setting
PR NewswireMajor Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible
PR NewswireSemler Announces Investment in Monarch Medical Technologies

Semler Scientific News

Semler Scientific News: auf dieser Seite finden Sie alle Semler Scientific News und Nachrichten zur Semler Scientific Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Semler Scientific News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Semler Scientific News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.